FAIL (the browser should render some flash content, not this).

Molecular Diagnostics

Directed by Nicholas Potter, PhD, FACMG, the molecular diagnostics laboratory at Molecular Pathology Laboratory Network, Inc. (MPLN) provides testing and consultation in three broad areas of laboratory medicine: oncology, inherited diseases and infectious diseases.

The laboratory’s comprehensive approach to the analysis of cancer uses several complementary methods, in addition to flow cytometry, cytogenetics and fluorescence in situ hybridization (FISH), the molecular diagnostic laboratory provides quantitative polymerase chain reaction (PCR) for minimal residual disease detection and therapeutic monitoring, gene sequenceing and mutation analysis. All of these technologies are provided within one facility thereby providing a StrataFLEX approach to:

  • Test selection
  • Disease evaluation
  • Daily consultation
  • Concordance analysis

With a long-term strategy to build a medical genetics division around a core offering of tests that target specific medical subspecialties, the molecular diagnostics division continuously expand its services. Current offerings include carrier and diagnostic testing for cystic fibrosis, molecular assessment of the risk of blood clots, or thromboses and specialized sequence-based testing for Friedreich's ataxia.

Utilizing automation and a host of contemporary technologies, the molecular diagnostic laboratory results more than 200,000 tests per year.